CPC
Consolidated Planning Corp’s Novo Nordisk NVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-48,796
| Closed | -$4.2M | – | 209 |
|
2024
Q4 | $4.2M | Sell |
48,796
-6,338
| -11% | -$545K | 0.57% | 58 |
|
2024
Q3 | $6.56M | Buy |
55,134
+1,038
| +2% | +$124K | 0.98% | 28 |
|
2024
Q2 | $7.72M | Buy |
54,096
+1,692
| +3% | +$242K | 1.27% | 19 |
|
2024
Q1 | $6.73M | Sell |
52,404
-3,759
| -7% | -$483K | 1.15% | 25 |
|
2023
Q4 | $5.81M | Buy |
56,163
+431
| +0.8% | +$44.6K | 1.08% | 25 |
|
2023
Q3 | $5.07M | Buy |
55,732
+28,521
| +105% | +$2.59M | 1.12% | 24 |
|
2023
Q2 | $4.4M | Buy |
27,211
+282
| +1% | +$45.6K | 0.93% | 33 |
|
2023
Q1 | $4.29M | Sell |
26,929
-14,038
| -34% | -$2.23M | 1.11% | 25 |
|
2022
Q4 | $5.54M | Buy |
40,967
+1,277
| +3% | +$173K | 1.53% | 16 |
|
2022
Q3 | $3.95M | Sell |
39,690
-1,156
| -3% | -$115K | 1.23% | 23 |
|
2022
Q2 | $4.55M | Buy |
+40,846
| New | +$4.55M | 1.42% | 17 |
|